메뉴 건너뛰기




Volumn 16, Issue 5, 2008, Pages 447-452

P16, Cyclin D1, Ki-67, and AMACR as markers for dysplasia in Barrett esophagus

Author keywords

methylacyl CoA racemase (AMACR); Adenocarcinoma; Barrett esophagus; Cyclin D1 (CCND1); Dysplasia; Immunohistochemistry; Ki 67; p16 (INK4A CDKN2A)

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; BIOLOGICAL MARKER; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; KI 67 ANTIGEN; ALPHA-METHYLACYL-COA RACEMASE; ISOMERASE; P16 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

EID: 55949118172     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e318168598b     Document Type: Article
Times cited : (36)

References (42)
  • 1
    • 0026748207 scopus 로고
    • Adenocarcinoma in Barrett's esophagus: A new epidemic?
    • Haggitt RC. Adenocarcinoma in Barrett's esophagus: a new epidemic? Hum Pathol. 1992;23:475-476.
    • (1992) Hum Pathol , vol.23 , pp. 475-476
    • Haggitt, R.C.1
  • 3
    • 0022253063 scopus 로고
    • The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus
    • Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med. 1985;313: 857-859. (Pubitemid 15250200)
    • (1985) New England Journal of Medicine , vol.313 , Issue.14 , pp. 857-859
    • Cameron, A.J.1    Ott, B.J.2    Payne, W.S.3
  • 5
    • 0027301539 scopus 로고
    • Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus
    • The Rotterdam Esophageal Tumor Study Group
    • Menke-Pluymers MB, Hop WC, Dees J, et al. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer. 1993;72:1155-1158.
    • (1993) Cancer , vol.72 , pp. 1155-1158
    • Menke-Pluymers, M.B.1    Hop, W.C.2    Dees, J.3
  • 7
    • 0023840926 scopus 로고
    • Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions
    • Reid BJ, Weinstein WM, Lewin KJ, et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology. 1988;94:81-90.
    • (1988) Gastroenterology , vol.94 , pp. 81-90
    • Reid, B.J.1    Weinstein, W.M.2    Lewin, K.J.3
  • 8
    • 0033869292 scopus 로고    scopus 로고
    • Long-term follow-up of Barrett's high-grade dysplasia
    • Weston AP, Sharma P, Topalovski M, et al. Long-term follow-up of Barrett's high-grade dysplasia. Am J Gastroenterol. 2000;95: 1888-1893.
    • (2000) Am J Gastroenterol , vol.95 , pp. 1888-1893
    • Weston, A.P.1    Sharma, P.2    Topalovski, M.3
  • 9
    • 0027993158 scopus 로고
    • Barrett's esophageus, dysplasia and adenocarcinoma
    • Haggitt RC. Barrett's esophageus, dysplasia and adenocarcinoma. Hum Pathol. 1994;25:982-993.
    • (1994) Hum Pathol , vol.25 , pp. 982-993
    • Haggitt, R.C.1
  • 13
    • 13444310790 scopus 로고    scopus 로고
    • Is There a way for pathologists to decrease interobserver variability in the diagnosis of dysplasia?
    • Montgomery E. Is There a way for pathologists to decrease interobserver variability in the diagnosis of dysplasia? Arch Pathol Lab Med. 2005;129:174-176.
    • (2005) Arch Pathol Lab Med , vol.129 , pp. 174-176
    • Montgomery, E.1
  • 14
    • 84966538496 scopus 로고    scopus 로고
    • Update on grading dysplasia in Barrett's esophagus
    • Montgomery E. Update on grading dysplasia in Barrett's esophagus. Pathol Case Rev. 2002;7:35-42.
    • (2002) Pathol Case Rev , vol.7 , pp. 35-42
    • Montgomery, E.1
  • 15
    • 0033859681 scopus 로고    scopus 로고
    • The diagnosis of dysplasia and malignancy in Barrett's oesophagus
    • DOI 10.1046/j.1365-2559.2000.00960.x
    • Geboes K, van Eyken P. The diagnosis of dysplasia and malignancy in Barrett's oesophagus. Histopathology. 2000;37:99-107. (Pubitemid 30608506)
    • (2000) Histopathology , vol.37 , Issue.2 , pp. 99-107
    • Geboes, K.1    Van Eyken, P.2
  • 16
    • 0035116072 scopus 로고    scopus 로고
    • Molecular biology of Barrett's adenocarcinoma
    • Wijnhoven BP, Tilanus HW, Dinjens WN. Molecular biology of Barrett's adenocarcinoma. Ann Surg. 2001;233:322-337.
    • (2001) Ann Surg , vol.233 , pp. 322-337
    • Wijnhoven, B.P.1    Tilanus, H.W.2    Dinjens, W.N.3
  • 17
    • 27244449307 scopus 로고    scopus 로고
    • Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: Evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications
    • DOI 10.1097/01.pas.0000170349.47680.e8
    • Powell EL, Leoni LM, Canto MI, et al. Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications. Am J Surg Pathol. 2005;29:1497-1504. (Pubitemid 41513300)
    • (2005) American Journal of Surgical Pathology , vol.29 , Issue.11 , pp. 1497-1504
    • Powell, E.L.1    Leoni, L.M.2    Canto, M.I.3    Forastiere, A.A.4    Iocobuzio-Donahue, C.A.5    Wang, J.S.6    Maitra, A.7    Montgomery, E.8
  • 18
    • 11144282431 scopus 로고    scopus 로고
    • p16 expression in Barrett's esophagus and esophageal adenocarcinoma: Association with genetic and epigenetic alterations
    • Hardie LJ, Darnton SJ, Wallis YL, et al. p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterations. Cancer Lett. 2005;217:221-230.
    • (2005) Cancer Lett , vol.217 , pp. 221-230
    • Hardie, L.J.1    Darnton, S.J.2    Wallis, Y.L.3
  • 21
    • 33645682837 scopus 로고    scopus 로고
    • Immunohistochemical evaluation of pRb2/p130, VEGF, EZH2, p53, p16, p21waf-1, p27, and PCNA in Barrett's esophagus
    • Merola E, Mattioli E, Minimo C, et al. Immunohistochemical evaluation of pRb2/p130, VEGF, EZH2, p53, p16, p21waf-1, p27, and PCNA in Barrett's esophagus. J Cell Physiol. 2006;207: 512-519.
    • (2006) J Cell Physiol , vol.207 , pp. 512-519
    • Merola, E.1    Mattioli, E.2    Minimo, C.3
  • 22
    • 31844446633 scopus 로고    scopus 로고
    • Subcellular localization, modification and protein complex formation of the cdk-inhibitor p16 in Rb-functional and Rb-inactivated tumor cells
    • DOI 10.1002/ijc.21466
    • Nilsson K, Landberg G. Subcellular localization, modification and protein complex formation of the cdk-inhibitor p16 in Rb-functional and Rb-inactivated tumor cells. Int J Cancer. 2006;118:1120-1125. (Pubitemid 43185597)
    • (2006) International Journal of Cancer , vol.118 , Issue.5 , pp. 1120-1125
    • Nilsson, K.1    Landberg, G.2
  • 23
    • 33947670366 scopus 로고    scopus 로고
    • Up-regulation of expression and lack of 50 CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas
    • Ivanova TA, Golovina DA, Zavalishina LE, et al. Up-regulation of expression and lack of 50 CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas. BMC Cancer. 2007;7:47.
    • (2007) BMC Cancer , vol.7 , pp. 47
    • Ivanova, T.A.1    Golovina, D.A.2    Zavalishina, L.E.3
  • 25
    • 33750817623 scopus 로고    scopus 로고
    • Aberrant cytological localization of p16 and CDK4 in colorectal epithelia in the normal adenoma carcinoma sequence
    • Zhao P, Mao X, Talbot IC. Aberrant cytological localization of p16 and CDK4 in colorectal epithelia in the normal adenoma carcinoma sequence. World J Gastroenterol. 2006;12:6391-6396. (Pubitemid 44712426)
    • (2006) World Journal of Gastroenterology , vol.12 , Issue.39 , pp. 6391-6396
    • Zhao, P.1    Mao, X.2    Talbot, I.C.3
  • 26
    • 0032770368 scopus 로고    scopus 로고
    • P53, p21 (Waf1/Cip1) and cyclin D1 protein expression and prognosis in esophageal cancer
    • Kuwahara M, Hirai T, Yoshida K, et al. p53, p21 (Waf1/Cip1) and cyclin D1 protein expression and prognosis in esophageal cancer. Dis Esophagus. 1999;12:116-119.
    • (1999) Dis Esophagus , vol.12 , pp. 116-119
    • Kuwahara, M.1    Hirai, T.2    Yoshida, K.3
  • 29
    • 11144330624 scopus 로고    scopus 로고
    • Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesis
    • DOI 10.1593/neo.04280
    • Lao-Sirieix P, Brais R, Lovat L, et al. Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesis. Neoplasia. 2004;6:751-760. (Pubitemid 40041493)
    • (2004) Neoplasia , vol.6 , Issue.6 , pp. 751-760
    • Lao-Sirieix, P.1    Brais, R.2    Lovat, L.3    Coleman, N.4    Fitzgerald, R.C.5
  • 30
    • 2542477282 scopus 로고    scopus 로고
    • Consistent immunostaining for cyclin D1 can be achieved on a routine basis using a newly available rabbit monoclonal antibody
    • DOI 10.1097/01.pas.0000126054.95798.94
    • Cheuk W, Wong KO, Wong CS, Chan JK. Consistent immunostaining for cyclin D1 can be achieved on a routine basis using a newly available rabbit monoclonal antibody. Am J Surg Pathol. 2004;28:801-807. (Pubitemid 38685895)
    • (2004) American Journal of Surgical Pathology , vol.28 , Issue.6 , pp. 801-807
    • Cheuk, W.1    Wong, K.O.Y.2    Wong, C.S.C.3    Chan, J.K.C.4
  • 31
    • 34247634690 scopus 로고    scopus 로고
    • Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia- Dysplasia-adenocarcinoma sequence
    • Griffiths EA, Pritchard SA, McGrath SM, et al. Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia- dysplasia-adenocarcinoma sequence. Br J Cancer. 2007;96: 1377-1383.
    • (2007) Br J Cancer , vol.96 , pp. 1377-1383
    • Griffiths, E.A.1    Pritchard, S.A.2    McGrath, S.M.3
  • 33
    • 0029119205 scopus 로고
    • The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence
    • Polkowski W, van Lanschot JJ, Ten Kate FJ, et al. The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence. Surg Oncol. 1995;4:163-171.
    • (1995) Surg Oncol , vol.4 , pp. 163-171
    • Polkowski, W.1    Van Lanschot, J.J.2    Ten Kate, F.J.3
  • 34
    • 0028888513 scopus 로고
    • Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus
    • Hong MK, Laskin WB, Herman BE, et al. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus. Cancer. 1995;75:423-429.
    • (1995) Cancer , vol.75 , pp. 423-429
    • Hong, M.K.1    Laskin, W.B.2    Herman, B.E.3
  • 39
    • 34249741574 scopus 로고    scopus 로고
    • Alpha-methylacyl-CoA Racemase/P504S overexpression in colorectal carcinoma is correlated with tumor differentiation
    • Shi X, Gong E, Wu X. Alpha-methylacyl-CoA Racemase/P504S overexpression in colorectal carcinoma is correlated with tumor differentiation. Appl Immunohistochem Mol Morphol. 2007;15: 175-180.
    • (2007) Appl Immunohistochem Mol Morphol , vol.15 , pp. 175-180
    • Shi, X.1    Gong, E.2    Wu, X.3
  • 41
    • 33746930644 scopus 로고    scopus 로고
    • AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease
    • DOI 10.1097/01.pas.0000213268.30468.b4, PII 0000047820060700000012
    • Dorer R, Odze RD. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease. Am J Surg Pathol. 2006;30:871-877. (Pubitemid 44264978)
    • (2006) American Journal of Surgical Pathology , vol.30 , Issue.7 , pp. 871-877
    • Dorer, R.1    Odze, R.D.2
  • 42
    • 33751208046 scopus 로고    scopus 로고
    • Expression of α-methylacyl-coenzyme a racemase in dysplastic Barrett's epithelium
    • DOI 10.1016/j.humpath.2006.06.009, PII S0046817706003789
    • Lisovsky M, Falkowski O, Bhuiya T. Expression of alphamethylacyl- coenzyme A racemase in dysplastic Barrett's epithelium. Hum Pathol. 2006;37:1601-1606. (Pubitemid 44792228)
    • (2006) Human Pathology , vol.37 , Issue.12 , pp. 1601-1606
    • Lisovsky, M.1    Falkowski, O.2    Bhuiya, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.